Section 1. Why are we doing this survey?

Your expertise is crucial in improving patient care during major surgeries. We understand from previous research that even minor blood pressure changes can lead to severe myocardial injury, with mortality risks. Patients with existing cardiac conditions often take ACE-inhibitors and ARBs, but deciding whether to continue these medications before surgery is complex and can affect outcomes.

The recent clinical trial SPACE, suggests stopping these drugs may increase the risk of myocardial injury, but the impact varies with cardiac disease type. We need your insights to better understand this treatment decision process.

Your survey responses will help refine guidelines, ensuring safer surgery for patients.